AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 247 filers reported holding AXSOME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,867,025 | -10.4% | 74,332 | -9.4% | 1.50% | -14.4% |
| Q1 2024 | $6,546,154 | +17.9% | 82,032 | +13.9% | 1.75% | +13.1% |
| Q4 2023 | $5,550,786 | +10.3% | 72,032 | 0.0% | 1.55% | +3.3% |
| Q3 2023 | $5,034,316 | -4.4% | 72,032 | 0.0% | 1.50% | +34.9% |
| Q2 2023 | $5,266,980 | -46.5% | 72,032 | -54.8% | 1.11% | -66.4% |
| Q1 2023 | $9,836,356 | – | 159,474 | – | 3.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |